| Group Editor Steve Fisher s.fisher@blmgroup.co.uk Editor Michael Fisher m.fisher@blmgroup.co.uk Journalist Editorial Contact Admin & Circulation |
Sales Director Angie Cooper a.cooper@blmgroup.co.uk Sales Sales Contact Design & Production Studio Contact |
| Postal Address: Pharma Business International, Armstrong House, Armstrong Street, GRIMSBY,N.E. Lincs., DN31 2QE England |
|
Home Contact Us
Contact Us
Latest news
Eisai strikes licensing agreement for anti-obesity agent in Latin America
Japanese pharma company Eisai has granted exclusive development and marketing rights for lorcaserin hydrochloride, its anti-obesity agent, to Brazil’s Eurofarma Laboratórios.
Lorcasrin, a generic of...
In brief: Abbott names new president
Chicago healthcare company Abbott has named Robert B. Ford as its new President and Chief Operating Officer.
Mr Ford is a 22-year veteran of Abbot...
Karuna kicks off Phase 2 study evaluating schizophrenia treatment
Karuna Pharmaceuticals has initiated a Phase 2 study evaluating the efficacy and safety of its lead product candidate, Karuna-Xanomeline-Trospium (KarXT), for treating psychosis in...
